background: Spermatogenesis is maintained by a dynamic balance between germ cell proliferation and apoptosis. Previous study has demonstrated that CD147 knockout mice are infertile with arrested germ cells. However, the question of whether and how CD147 may be involved in the apoptotic process during spermatogenesis remains elusive. The aim of this study was to evaluate the role of CD147 in the regulation of germ cell apoptosis in mice.
Introduction
Spermatogenesis is a unique process that involves a series of cellular and biochemical events, stepping from mitosis of spermatogonia, meiosis of spermatocyte, to spermiogenesis (de Kretser et al., 1998) . Thus, the process must be under precise regulation to attain a homeostatic state that ensures the quality and quantity of mature spermatozoa. This fine-tuned homeostasis is, however, achieved at a substantially high cost in which up to 75% of germ cells from various stages undergo apoptosis in the testis (Huckins, 1978 ; Allan both extrinsic and intrinsic pathways in germ cells are executed by activation of the caspase family (Kawamura et al., 2004; Said et al., 2004; Theas et al., 2006; Yin et al., 2007; Sofikitis et al., 2008; Aitken et al., 2011) . It has been demonstrated that p53 acts as a key player in the cellular response to multiple stresses and promotes apoptosis in both extrinsic and intrinsic pathways during spermatogenesis (Fridman and Lowe, 2003) . Three transmembrane proteins [Fas/CD95, DR5 and poly ADP-ribose polymerase (PARP)] serve as the targets of p53-mediated extrinsic apoptotic cell death and have been implicated in responses to g-irradiation and other stimuli (Wu et al., 1997; Bouvard et al., 2000; Burns et al., 2001) . On the other hand, a p53-mediated intrinsic apoptotic pathway has been demonstrated to activate a pro-apoptotic subset of bcl-2 family genes, including Bax, Noxa, Bid and puma (Fridman and Lowe, 2003) . Despite of all these findings, p53-dependent apoptosis has been reported to be cell type specific during germ cell development (Coates, 2007; Aitken et al., 2011) .
CD147 is a multifunctional trans-membrane glycoprotein, which belongs to the immunoglobulin superfamily. While the role of CD147 in migration and metastasis of cancer cells has been well established (Kanekura and Chen, 2010; Weidle et al., 2010; Wu et al., 2011) , recent studies have revealed that knockdown of CD147 by small-interfering RNA or blocking functional CD147 with a specific antibody inhibit the proliferation and tumorigenecity of multiple cancer cells (Chen et al., 2006; Abraham et al., 2008; Wang et al., 2010; Zhu et al., 2011) or induce massive cell death in colon (Baba et al., 2008) and liver cancer cells (Hou et al., 2011) . These results suggest that CD147 has dual roles in regulating both migration and cell survival in cancer cells. In our previous study, we demonstrated that CD147 regulates the migration of spermatogonia and spermatocytes via the induction of matrix metalloproteinases-2 (MMP-2) during spermatogenesis . Interestingly, CD147-knockout mice are infertile with arrested and degenerated germ cells in the seminiferous tubules. Moreover, some of the degenerated germ cells exhibit characteristics of apoptosis (Toyama et al., 1999) . These observations suggest that CD147 might not only be required for the migration of germ cells but also involved in the regulation of germ cell apoptosis during spermatogenesis. Thus, we undertook the present study to elucidate the function of CD147 in germ cell apoptosis both in vitro and in vivo. The results have demonstrated that immunodepletion of CD147 in mouse testis results in a significant increase in apoptosis in spermatocytes primarily but not other germ cells, through p53-independent activation of caspase 3 and PARP. In addition, anti-CD147 neutralizing antibody inhibits the viability of, and induces apoptosis in, GC-2 cells (immortalized spermatocytes) but not GC-1 cells (immortalized spermatogonia) in culture. These results have revealed a novel spermatocyte-specific apoptotic mechanism involving CD147, which may serve as an important survival factor for spermatocytes during spermatogenesis.
Materials and Methods

Animals
Eight-week old male severe combined immunodeficiency (SCID) mice were used in this study. All experiments were performed under the license from the government of the Hong Kong SAR and were endorsed by the animal experimentation ethics committee of the Chinese University of Hong Kong.
Cell cultures
GC-1 and GC-2 cells were purchased from the American Type Culture collection (ATCC) (ATCC number: CRL-2053 and CRL-2196, respectively) and grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (FBS) and 1% Penicillin-Streptomycin and maintained in a 5% CO 2 incubator at 378C. Adherent cells were sub-cultured every 2 days.
In vivo seminiferous tubule injection
The seminiferous tubules injection was carried out as described, with slight modification (Ogawa et al., 1997) . Briefly, SCID mice were anesthetized and the testes were exteriorized through a midline abdominal incision. Mouse anti-CD147 antibody [kindly given by Dr Jianli Jiang (Dai et al., 2009; Jia et al., 2009) ] suspension (40 mg/ml, dissolved in 0.04% trypan blue) was injected into the seminiferous tubules through the efferent duct. Successful injection filled 70% of the surface area of the testis. As controls, we injected an equal amount of normal mouse immunoglobulin (Ig)G into the contralateral seminiferous tubules of the same mice. Sham surgeries were included in the study to monitor the effect of surgical stress on spermatogenesis. In sham surgery, micropipettes were pierced the efferent duct without injection.
Western blot
The testes were harvested in a lysis buffer [RAPI buffer: 50 mM TrisHCl, pH 8.0, 150 mM NaCl, 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% sodium dodecyl sulphate (SDS)]. Total lysates of testis (40 mg per lane) for different groups were subjected to SDS-polyacrylamide gel electrophoresis and transferred onto nitrocellulose membranes (Schleicher & Schuell, Dasse, Germany). The membrane was blocked by TBST (10 mM Tris -Cl, pH 8.0; 150 mM NaCl; 0.05% Tween 20) plus 5% fat-free milk, washed three times with TBST and then incubated with primary antibodies in TBST plus 1.5% fat-free milk at 48C overnight. Antibodies used in the study are listed in Supplementary data, Table SI. The membrane was subsequently washed with TBST and incubated for 1 h with peroxidase-conjugated secondary antibody. The membrane was washed three times with TBST and signals were detected by enhanced chemiluminescence (Amersham, Piscataway, NJ, USA).
Histology
Mice were anesthetized and perfused with 4% paraformaldehyde (PFA) for pre-fixation. The testes were removed and fixed for at least 24 h by immersion in 4% PFA. Tissues were then processed for paraffin embedding and sectioning by routine methods.
Cell viability assay
Cell viability was analyzed by CellTiter 96
w AQueous Non-Radioactive Cell Proliferation Assay (Promega Corporation, USA) as described. GC-1 or GC-2 cells (1 × 10
TUNEL assay
The terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay was performed using a Fluorescein In Situ Cell Death Detection kit (Roche Applied Science, Germany) as described. Briefly, testes sections or treated GC-1/GC-2 cells were fixed with 4% PFA and washed three times with phosphate-buffered saline (PBS). The samples were incubated for 1 h in TUNEL reaction solution (50 ml enzyme solution + 450 ml label solution) at 378C in the dark. The reaction solutions were removed and slides were washed three times (5 min each) with PBS. The nuclei were stained with 300 nM 4 ′ ,6-diamidino-2-phenylindole (DAPI). The slides were mounted with ProLong Gold Antifade Reagent (Invitrogen) and visualized using a NIKON microscope (NIKON Corp, Tokyo, Japan) with ×10 objective. Identification of different stages of germ cells was achieved using an established morphological standard (Russell et al., 1990) and DAPI-bright heterochromatin cluster distribution of stage-specific germ cells (Scherthan et al., 1996; Scherthan et al., 2000) . The corresponding data were analyzed with the MetaMorph w Microscopy Automation & Image Analysis Software (Molecular Devices, LLC., USA) with gating for cell size and round shape to exclude the signals from spermatids and non-specific staining.
Statistical analysis
All morphometric data were collected blind (six random fields/section and total six mice). Statistics for comparison between two measurements were analyzed by unpaired or paired two-tailed Student's t-test. One-way or two-way analysis of variance was used for analysis involving more than two measurements. Values of P , 0.05 were considered as significant. Graphpad Prizm 5.0 (GraphPad Software, Inc., CA., USA) was used in all statistical analysis.
Results
Immunodepletion of CD147 in vivo
Nine days after the injection of CD147 monoclonal antibody, the size (Fig. 1A) and weight of the testes was significantly reduced in anti-CD147 injected mice compared with the control mice, injected with IgG, with a testis weight to body weight ratio of 0.4455 + 0.017 versus 0.6460 + 0.044, respectively, P , 0.001 (Fig. 1B) . In addition, histological analysis of immunodepleted testis sections revealed that the blocking of CD147 reduced the number of spermatogenic cells and altered the tubular structure of seminiferous tubules, compared with control IgG-injected testes. Interestingly, nuclear condensation and fragmentation, morphologies which are indicative of apoptotic cells, were frequently observed in germ cells from CD147-depleted testes (Fig. 1C) , suggesting that CD147 may be involved in regulating germ cell apoptosis.
CD147 immunodepletion results in apoptosis of spermatocytes in vivo
To confirm the role of CD147 in the regulation of apoptosis in germ cells, we used TUNEL assay to evaluate the apoptotic cells in the seminiferous tubules of anti-CD147-injected mice (Fig. 2) . Only a small number of apoptotic cells were observed at Stages I -X in testicular sections from sham testis [percentage apoptotic cells per field: mean + SEM: 0.29% + 0.12%)], CD147-immunodepleted and normal IgG-injected testes. Strikingly, the blocking of CD147 resulted in a marked increase in apoptotic cells (mean + SEM: 7.02% + 1.53%) as compared with the normal, IgG-injected group (mean + SEM: 1.01% + 0.11%) at Stages XI-XII of the seminiferous tubules (P , 0.001). Of particular interest, we observed that cellular apoptosis mainly occurred in spermatocytes rather than other germ cells, as characterized by distinctive morphology and nuclear heterochromatin clusters distribution (Fig. 2A, white arrowheads) . Taken together, Inhibiting CD147 induces mouse germ cell apoptosis these results suggest that CD147 may be involved in the regulation of apoptosis in germ cells, particularly spermatocytes.
Blocking of CD147 leads to p53-independent activation of caspase 3 and PARP in vivo
To elucidate the signaling pathways involved in the regulation of germ cell apoptosis elicited by CD147, we determined the levels of p53 and two hallmark effectors, caspase 3 and PARP, by western blot. As shown in Fig. 2C and D, levels of cleaved caspase 3 and cleaved PARP showed a remarkable increase in anti-CD147-treated mice compared with that of the IgG control group, while the level of p53 was not altered. These results indicate that the blocking of CD147 resulted in p53-independent activation of caspase 3 and PARP.
CD147 regulates apoptosis in spermatocytes but not spermatogonia in vitro
We have observed that immunodepletion of CD147 leads to apoptosis of spermatocytes but not spermatogonia in vivo ( Fig. 2A ). This could be because spermatogonia were not readily exposed to the injected antibody in the lumen of the seminiferous tubules. To further verify the discrete pro-apoptotic response between spermatocytes and spermatogonia, we attempted to block CD147 in GC-1 and GC-2 cells in vitro and determined apoptosis by cell viability assay and TUNEL assay. We first confirmed the membrane expression of CD147 in GC-1 and GC-2 cells by western blot using membrane and cytoplasmic fractions. CD147 was detected in membrane fractions but not in cytoplasmic fractions of both GC-1 and GC-2 cells (Fig. 3A) . As shown in Fig. 3B , the viability of GC-2 cells was significantly inhibited, in a time-dependent manner, when treated with 10 mg/ml of anti-CD147 antibody. In contrast, blocking of CD147 did not change the viability of GC-1 cells (Fig. 3C) , suggesting that CD147 was involved in regulating germ cell survival in spermatocytes but not spermatognia during spermatogenesis.
The decrease in viability of GC-2 cells after blocking CD147 could result from either inhibited proliferation or enhanced apoptosis. To distinguish these two possibilities, a TUNEL assay was performed in both GC-1 and GC-2 cells after treatment with CD147 antibody. As shown in Fig. 4A , a significantly increased number of apoptotic GC-2 cells was observed in the anti-CD147-treated group (mean + SEM: 3.039% + 0.434%) compared with the IgG control (mean + SEM: 0.553% + 0.187%) and blank control group (mean + SEM: 0.801% + 0.224%) at 24 h. The number of apoptotic GC-2 cells in the CD147-immunodepleted group was significantly increased (mean + SEM: 7.217% + 0.579%) at 48 h post-treatment (Fig. 4B) when compared with the IgG control (mean + SEM: 0.688% + 0.089%) and blank control (mean + SEM: 0.572% + 0.145%). We also determined the effect of CD147 antibody on GC-1 cells. Consistent with the in vivo observation and cell viability assay result in GC-1 cells, the blocking of CD147 did not induce apoptosis of GC-1 cells (Supplementary data, Fig. S1 ).
To further investigate the underlying mechanism of spermatocyte apoptosis induced by CD147 immunodepletion observed in vivo, GC-2 cells were treated with 10 mg/ml anti-CD147 antibody for 48 h and the levels of cleaved caspase 3 and PARP were examined by western blot. Consistent with the in vivo data, the level of cleaved caspase 3 and PARP was increased in the anti-CD147-treated group, while no changes were observed in the total caspase 3 and p53. Interestingly, the total PARP was decreased in anti-CD147-treated GC-2 cells (Fig. 4C and D) . These data suggested that activation of caspase 3 and PARP by depleting CD147 was independent of p53. Since activation of p53 could be mediated by nuclear -cytoplasmic shuttle, it is plausible that depletion of CD147 may lead to activation of p53 without altering its expression. To test this possibility, we cultured GC-2 cells at 398C, which has been shown to inactivate p53 (Hofmann et al., 1994) , and examined the effect of depleting CD147. Indeed, the viability of GC-2 cells was significantly reduced with enhanced apoptosis in the absence of p53 activation Figure 4 Anti-CD147 treatment induces apoptosis of spermatocytes. TUNEL staining of GC-2 cells treated with anti-CD147 antibody for 24 h (A) and 48 h (B), and quantification of TUNEL-positive cells. Data are presented as mean + SEM from two independent experiments. **P , 0.01; ***P , 0.001. (C) Western blot analysis of apoptotic factors induced by anti-CD147 treatment in GC-2 cells. Cleaved caspase 3 and its downstream molecule (cleaved PARP) were increased in the anti-CD147 treated group, while the level of full-length caspase 3 and p53 was not altered. Beta-tubulin was used as the loading control. (D) The corresponding statistical analysis (*P , 0.05 versus IgG control) and the experiments were repeated three times. Values are mean + SEM.
Inhibiting CD147 induces mouse germ cell apoptosis (Supplementary data, Fig. S2 ). These results confirmed that CD147 deprivation induces spermatocyte apoptosis through p53-independent signaling pathways.
Discussion
Apoptosis of testicular germ cells is crucial for spermatogenesis in mammals. As in somatic cells, hormones, growth factors and other mitogenic signals determine survival and/or proliferation of germ cells. In addition, the molecular mechanisms involved in the regulation of apoptosis are highly conserved and have been shown to play a key role in the spermatogenic process (Aitken et al., 2011) . It has long been demonstrated that germ cells are arrested and degenerated in infertile CD147-knockout mice (Toyama et al., 1999) . However, at what stage and how CD147 contributes to this phenotype remains elusive. The present study has clearly demonstrated, for the first time, that CD147 is critical for the survival of spermatocytes through a p53-independent pathway although CD147 was recently shown to have a function in regulating migration of germ cells . In keeping with its anti-apoptotic role in cancer (Kuang et al., 2009; Hao et al., 2010) , we have demonstrated that interfering with CD147 function results in a significant reduction in testicular size and weight compared with control, which is attributed to enhanced apoptosis-related germ cell loss (Figs 1 and 2 ). This result is further confirmed by our in vitro study using GC-2 cells, which shows a timedependent increase in apoptotic cells in response to CD147 antibody (Fig. 3) . In addition, western blot analysis further demonstrates the activation of an apoptosis signal cascade (caspase 3) and its downstream effector PARP in both the mouse model and GC-2 cells. These findings have provided a possible mechanism underlying the long observed germ cell arrest and degeneration in the CD147-knockout mouse model.
While a complex network of regulatory pathways has been implicated in the control of germ cell apoptosis, cell death during spermatogenesis in mice and rats has been suggested to involve caspases 2, 3, 8 and 9, indicating the activation of both extrinsic and intrinsic pathways of apoptosis (Moreno et al., 2006; Shaha et al., 2010) . Intriguingly, it has been proposed that bcl-2 family proteins and p53 are more critical to the intrinsic pathway, whereas the FAS pathway contributes more to the extrinsic pathway during spermatogenesis (Shaha et al., 2010) . Although we do not fully understand the downstream signaling pathways leading to apoptosis resulting from CD147 depletion, our study has demonstrated that the apoptosis induced by functional depletion of CD147 is not dependent on p53 or bcl-2 and bax (Figs 2 and 4 and Supplementary data, Fig.  S3 ). Thus, we speculate that the extrinsic apoptotic pathway is more involved in CD147 deprivation-induced apoptosis in spermatocytes.
A previous study had shown that spontaneous apoptosis of germ cells was mainly observed at Stages XI -XII but was rarely seen at other stages in the seminiferous tubules in normal testis (Koji et al., 2001) . In this study, we have also demonstrated that depleting functional CD147 increased the percentage of germ cells undergoing apoptosis at Stages XI -XII in the seminiferous tubules, suggesting that CD147 is required for the regulation of the endogenous apoptotic programme. Intriguingly, the anti-apoptotic role of CD147 is germ cell type specific, namely in spermatocytes but not spermatogonia. On the one hand, this observation indicates that the apoptotic response in the diverse kinds of germ cells present within the testis is controlled by distinct mechanisms. On the other hand, it suggests that the dual role of CD147 in male germ cell development is stage specific, most likely during spermatocyte migration and differentiation. After completion of a series of mitoses, the differentiated spermatogonia detach from the basement membrane and enter the meiotic cycle, forming the preleptotene spermatocytes (Mruk and Cheng, 2010) . The primary spermatocytes then migrate across the blood -testis barrier towards the adluminal compartment in which the germ cells are surrounded by Sertoli cells and extracellular matrix (Cheng and Mruk, 2002) . Further differentiation of primary spermatocytes is associated with migration towards the lumen of seminiferous tubules. While our previous study has shown that depletion of functional CD147 decreases MMP-2 activity and migration rate in both GC-1 and GC-2 cells , the current study has demonstrated that CD147 deprivation induces apoptosis in GC-2 but not GC-1 cells. These findings are consistent with the observation by immunefluorescence that the TUNEL-positive signals accumulate at the spermatocytes rather than other germ cell types after CD147 antibody treatment (Fig. 2) . Thus, we propose that the dual functionality of CD147 in spermatocytes may provide a quality control mechanism of ensuring the migration of spermatocytes for differentiation, which otherwise would undergo apoptosis. In agreement with this hypothesis, we have observed a remarkable increase in the expression of CD147 at 21 days post-partum when spermatocytes are the main germ cells in the seminiferous tubules . The dynamic changes in the expression profile of CD147, along with its anti-apoptosis role, are consistent with the notion that up-regulation of CD147 promotes the survival and migration of spermatocytes, failure of which could result in apoptosis and degeneration of germ cells, as observed in CD147-knockout mice.
The present study has used spermatocyte cell lines and in vivo seminiferous tubule injection models to elucidate the role of CD147 in endogenous apoptosis of spermatocytes. However, the role of CD147 in regulating apoptosis of more differentiated germ cells should not be overlooked. As no cell lines for spermatids and spermatozoa are available, immunodepletion in the seminiferous tubules could be a method to study the role of CD147 in more differentiated germ cells. Indeed, we have observed an increase in apoptosis of elongated spermatids in CD147-depleted testis (data not shown). However, since the injection procedure would flush off spermatids and spermatozoa in the lumenal compartment, we are not able to define the effect of CD147 on these differentiated germ cells. Further studies, such as spermatid-specific knockout or testis organ culture, are required to demonstrate the role of CD147 in regulating apoptosis of spermatids and spermatozoa.
In conclusion, the present study has demonstrated a novel apoptosis regulation mechanism involving CD147 in spermatocytes. Together with our previous study , the present findings provide novel insights into the biological roles of CD147 in controlling germ cell apoptosis and migration, and thus a new molecular mechanism regulating spermatogenesis. Further studies evaluating the correlations between the expression of CD147 in patients with testicular cancer and in azoospermic patients may provide a potential diagnostic marker and a target for male contraceptives.
